Pre-eclampsia part 2: prediction, prevention and management.
about
Gestational weight gain and medical outcomes of pregnancyPre-eclampsia part 1: current understanding of its pathophysiology.Gestational Diabetes Mellitus Is Associated with Altered Neutrophil ActivityInsights into the Role of Helicobacter pylori Infection in Preeclampsia: From the Bench to the BedsideMiR-519d-3p suppresses invasion and migration of trophoblast cells via targeting MMP-2.Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromesEpigenetics and Preeclampsia: Defining Functional Epimutations in the Preeclamptic Placenta Related to the TGF-β PathwayEffects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placentaInfluence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia.Systematic Review of Micro-RNA Expression in Pre-Eclampsia Identifies a Number of Common Pathways Associated with the DiseasePrediction of Preeclampsia by First Trimester Combined Test and Simple Complete Blood Count Parameters.Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?The atrial natriuretic peptide (ANP) knockout mouse does not exhibit the phenotypic features of pre-eclampsia or demonstrate fetal growth restriction.The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study.Pulsatility index in combination with biomarkers or mean arterial pressure for the prediction of pre-eclampsia: Systematic literature review and meta-analysis.Measuring high-altitude adaptation.The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study.Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity.Helicobacter pylori infection and risk of preeclampsia: a systematic review and meta-analysis.Maternal plasma-soluble ST2 concentrations are elevated prior to the development of early and late onset preeclampsia - a longitudinal study.Failure of physiologic transformation of spiral arteries, endothelial and trophoblast cell activation, and acute atherosis in the basal plate of the placenta.Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study.Expectant management of severe preterm preeclampsia: a comparison of maternal and fetal indications for delivery.Abnormal CYP11A1 gene expression induces excessive autophagy, contributing to the pathogenesis of preeclampsia.Placental Basement Membrane Proteins are Required for Effective Cytotrophoblast Invasion in a 3D Bioprinted Placenta Model.The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio).Is an episode of suspected preterm labor that subsequently leads to a term delivery benign?The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.Seasonal variation in the prevalence of preeclampsia.Excessive Neutrophil Activity in Gestational Diabetes Mellitus: Could It Contribute to the Development of Preeclampsia?Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia
P2860
Q28067095-3F7DEBC0-E270-4811-8782-CE5F002FFFAAQ33416340-2019B3C6-4D18-44E6-806D-FA96864DB708Q33794472-4D17D965-1B84-4CFF-A228-3CD620BD31B8Q34312652-AFF78559-0820-4642-AD6C-37D50FDBD65DQ35214428-82A45FCE-EF06-4D03-AAB3-76DCAC5BBDE9Q35547367-82D105DA-4A44-44B7-B1C7-8A3F9B7E8821Q35824650-A9AE16C8-D44F-45FD-BA57-F089CF8EB519Q36024649-BDD9F1D0-B7DD-4BC0-AB6E-E876223F140AQ36034800-5355C823-144D-4DEF-A068-AA43F6ECFBEBQ36104833-143204DB-B952-4B2B-8EA5-3F1A7850D0D3Q36343649-05BFB1E0-68A5-4B8C-AC75-61E1B6EF3BC4Q36357099-9E686E42-D59B-47E9-AED6-4B4BA1CD31C3Q36981696-164D6966-C127-40FE-999B-8BF0A8CC2408Q38436237-4A639E62-96F2-48FF-B121-4860235ED7E1Q38543855-1D45E087-2325-4AC9-AD38-EBB6E4A5D324Q38634773-DC9B37C0-B66A-4D9B-BDA4-44A6CBB904EBQ38664824-5DF0074A-97E1-40FF-BE7B-5F91D03C589EQ39376655-0360DEDD-9787-4E42-BF4C-9A40104DB3ACQ40049011-F2C471AE-F0A2-4341-B6B2-FFB809A302D0Q40367971-4640FA21-11CF-493C-8F47-20AEDCE1003BQ40402667-2A50577E-C2D2-44C0-9287-094178A2D260Q41033848-D1CE35DE-01D5-46DA-8507-ADE1A9049DF3Q46309172-991AF493-FADE-49B3-9DF6-74957AE9091EQ47099319-E772B01C-D3FB-404E-B965-E5AA8BC3FFD4Q47546216-C4342B8C-9292-4004-B4A7-E85B854B83E2Q47645647-46BCE849-32F9-418B-8F80-F84923A4B627Q49243157-A21DD902-9174-4007-8015-5ED51F6C5B44Q49312791-8812D7DB-9774-45A2-B7C6-F14A92AFE8E4Q55165896-9D603708-6D63-4302-A418-2058B7129723Q57300007-AD8400C9-7067-44A9-87AC-E2DD21549623Q58795465-21E0354B-E182-4408-9568-81EFA986C7A8
P2860
Pre-eclampsia part 2: prediction, prevention and management.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pre-eclampsia part 2: prediction, prevention and management.
@en
type
label
Pre-eclampsia part 2: prediction, prevention and management.
@en
prefLabel
Pre-eclampsia part 2: prediction, prevention and management.
@en
P2860
P50
P356
P1476
Pre-eclampsia part 2: prediction, prevention and management.
@en
P2093
Piya Chaemsaithong
P2860
P2888
P304
P356
10.1038/NRNEPH.2014.103
P407
P577
2014-07-08T00:00:00Z